Skip to main content

Table 1 Shows reported use of specific treatments for JLS by clinician group

From: PReS-FINAL-2119: United Kingdom survey of current management of juvenile localised scleroderma

Treatment Used

Reported use by prs (% of respondents)

Reported use by dms (% of respondents)

Topical treatments

Systemic steroids

Ultraviolet light

Methotrexate

Ciclosporin

Hydroxychloroquine

Anti-TNF

Mycophenolate mofetil

Cyclophosphamide

10

90

0

100

30

40

60

90

30

100

79

68

96

32

11

4

18

0